Sold
Available
IBL-26-2814

Skin whitening composition containing acetyl tributyl citrate as an active ingredient

Listed on
2026-10-27
Skin whitening composition based on acetyl tributyl citrate for inhibiting melanin production

This technology features a whitening composition containing acetyl tributyl citrate or its salts as an active ingredient, which brightens skin tone by inhibiting both tyrosinase activity and melanin synthesis. The same ingredient can be formulated into cosmetic, pharmaceutical, and food compositions to prevent and improve conditions related to melanin overproduction.

While tyrosinase inhibitors like arbutin and kojic acid, along with vitamin C derivatives, have been standard whitening ingredients, they have faced issues such as limited efficacy or reported side effects like skin irritation. Since melanin overproduction is linked not only to hyperpigmentation like melasma and age spots but also to melanoma, there has been a need for safe and highly effective whitening ingredients.

This technology reduces the actual amount of pigment produced by simultaneously inhibiting tyrosinase, the starting point of the melanin production pathway, and subsequent pigment synthesis stages. It targets conditions such as melasma, freckles, lentigo, age spots, and post-inflammatory hyperpigmentation. It can be applied to functional whitening cosmetics, hyperpigmentation treatments, and inner beauty foods, allowing for the development of both topical and ingestible products using a single ingredient.

‍

‍

Key Features:
  • A cosmetic composition for skin whitening comprising acetyl tributyl citrate or a cosmetically acceptable salt thereof as an active ingredient
  • A cosmetic composition for skin whitening wherein the active ingredient exhibits both tyrosinase activity inhibition and melanin synthesis inhibition
  • A cosmetic composition for preventing or improving diseases related to melanin overproduction in skin tissue, such as melasma, freckles, lentigo, age spots, and post-inflammatory hyperpigmentation
  • A pharmaceutical composition for treating and a food composition for improving diseases related to melanin overproduction, comprising acetyl tributyl citrate or a pharmaceutically or nutritionally acceptable salt thereof as an active ingredient

‍

Yonsei University
Tae-sun Park | Wi-seok Kang
Document
Date of application:
2024-04-08
|
Patent registration number:
10-2918091
Industry
cosmetics
healthcare•pharm
Technology
Bio/Pharmaceutical
Country
Korea
Family Patent

N/A

Price
Price negotiable
Subscribe to our newsletter to receive the latest patent information faster than anyone else.
← Back to list